MAPT and Alzheimer disease: A postmortem neuron-specific DNA methylome study revealed that the BRCA1 promoter was hypomethylated in AD, accompanied by a reduced BRCA1 expression in the nuclei but an increased expression in the cytosol, especially in tau-bearing insoluble aggregates [65].